Ardena | News & Insights

NewsPress Release
01.09.2021

Ardena acquires Idifarma from Suanfarma, adding spray drying technology and high potency capabilities

Read more
Ardena’s expertise on drug substance development helps new treatment for Parkinson’s disease to the next phase featured image

NewsPress Release
30.08.2021

Ardena’s expertise on drug substance development helps new treatment for Parkinson’s disease to the next phase

Read more
Ardena’s success leads to major €35 million investment for expansion in Belgium, Sweden and The Netherlands featured image

NewsPress Release
14.07.2021

Ardena’s success leads to major €35 million investment for expansion in Belgium, Sweden and The Netherlands

Read more
Citryll enters into bioanalytics partnership with Ardena for the clinical development of CIT-013, antagonist of NET biology and associated pathologies featured image

NewsPress Release
12.07.2021

Citryll enters into bioanalytics partnership with Ardena for the clinical development of CIT-013, antagonist of NET biology and associated pathologies

Read more
Commercial Agency Agreement between Ardena and South Korean company Keyfronbio Co., Ltd. featured image

News
15.06.2021

Commercial Agency Agreement between Ardena and South Korean company Keyfronbio Co., Ltd.

Read more

News
18.05.2021

Investment in Flow Cytometry unlocks the secrets of single cells

Read more
New cancer immunotherapy treatment enters clinical phase featured image

NewsPress Release
27.04.2021

New cancer immunotherapy treatment enters clinical phase

Read more
Launch new Ardena career page featured image

Insights
30.03.2021

Launch new Ardena career page

Read more
Patrick Walleser, new Ardena Account Management Director DACH region featured image

Insights
23.02.2021

Patrick Walleser, new Ardena Account Management Director DACH region

Read more
Commercial Agency Agreement Taiwan (ROC) featured image

News
24.11.2020

Commercial Agency Agreement Taiwan (ROC)

Read more